首页> 外文期刊>Journal of minimally invasive gynecology >Tension-free vaginal tape-O and -Secur for the treatment of stress urinary incontinence: a thirty-six-month follow-up single-blind, double-arm, randomized study.
【24h】

Tension-free vaginal tape-O and -Secur for the treatment of stress urinary incontinence: a thirty-six-month follow-up single-blind, double-arm, randomized study.

机译:无张力阴道带-O和-Secur用于治疗压力性尿失禁:三十六个月的单盲,双臂,随机随访研究。

获取原文
获取原文并翻译 | 示例
       

摘要

To compare the efficacy of the inside-out tension-free vaginal tape-obturator (TVT-O) device versus the single-incision TVT-Secur device 36 months after the procedure.A single-blind, randomized, parallel-group study on 154 patients with stress urinary incontinence (77 treated with TVT-O and 77 with the TVT-Secur hammock approach). The primary endpoint was the objective cure rate 36 months after the procedure evaluated with the challenge stress test. Secondary endpoints were subjective cure rate (evaluated with bladder diary, quality-of-life questionnaires, and patient-reported outcome tools) and intraoperative and postoperative complications. The primary endpoint was evaluated with a noninferiority study design.Sixty-six patients in the TVT-O group and 64 in the TVT-Secur group concluded the study. Thirty-six months after the procedure, 57/66 patients (86.4%) in the TVT-O and 50/64 (78.1%) in the TVT-Secur groups were objectively cured (noninferiority unilateral u test: p < .05). No differences were observed in the subjective cure and complication rates.TVT-Secur seems not to be inferior to TVT-O in the surgical treatment of stress urinary incontinence and causes less postoperative pain. The possibility of severe blood loss cannot be ruled out when TVT-Secur is used.
机译:在手术后36个月,比较由内而外的无张力阴道胶带封闭器(TVT-O)与单切口TVT-Secur装置的疗效。一项针对154例的单盲,随机,平行分组研究压力性尿失禁患者(TVT-O治疗77例,TVT-Secur吊床治疗77例)。主要终点是用挑战压力测试评估手术后36个月的客观治愈率。次要终点是主观治愈率(通过膀胱日记,生活质量问卷和患者报告的结局工具评估)以及术中和术后并发症。主要终点指标采用非劣效性研究设计进行评估。TVT-O组中的66例患者和TVT-Secur组中的64例患者完成了研究。手术后36个月,TVT-O组57/66例患者(86.4%)和TVT-Secur组50/64例患者(78.1%)得到了客观治愈(非劣效性单侧u检验:p <.05)。在主观治愈和并发症发生率上没有差异。TVT-Secur在压力性尿失禁的外科治疗中似乎并不逊色于TVT-O,并减少了术后疼痛。使用TVT-Secur不能排除严重失血的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号